Leonteq Securities’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELTX
Leonteq Securities's ELTX Position: Q3 2026 in Review
Leonteq Securities held its Elicio Therapeutics (ELTX) position steady in Q3 2026 at 20,000 shares worth $36.4K. The position accounts for ﹤0.01% of the portfolio, ranked #835.
Leonteq Securities first reported a position in ELTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $78.2K in Q2 2026. 57 funds tracked by Wall St. Rank hold ELTX as of Q3 2026.
- Leonteq Securities held 20,000 shares of Elicio Therapeutics worth $36.4K as of Q3 2026.
- Leonteq Securities left its Elicio Therapeutics share count unchanged in Q3 2026.
- Elicio Therapeutics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #835 holding.
- Leonteq Securities first reported a position in Elicio Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Leonteq Securities's Elicio Therapeutics position peaked at $78.2K in Q2 2026.
- 57 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.